Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02937870 · ClinicalTrials.gov registry record · NA

A Bite Force Study Comparing Two New Test Adhesives With Currently Marketed Denture Adhesive

A NA study of Denture Retention, sponsored by GlaxoSmithKline.

Completed
Registry status
NA
Development phase
25
Enrollment target
1
Study location

NCT02937870 is a NA study of Denture Retention that has completed, run by GlaxoSmithKline. The registered enrollment target is 25 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02937870, a NA study of Denture Retention, has completed, sponsored by GlaxoSmithKline.

COMPLETED
Registry status
NA
Development phase
25 participants
Enrollment target
1
Study location

Study Summary

The objective of this 4-treatment, 4-period, randomized, crossover, proof of principle bite force study will be to compare bite force measurements over a 12 hour period across two (test) cream denture adhesives, with a currently marketed cream denture adhesive (positive control), and a negative/no treatment control.

Conditions Studied

Interventions

  • DEVICE Test Product 1
  • DEVICE Test Product 2
  • DEVICE Reference Product
  • OTHER Negative Control

Study Locations (1)

New Jersey

  • GSK Investigational Site - Bloomfield

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2017-03-07
Est. Completion 2017-04-05
Phase NA

Sponsor

GlaxoSmithKline

1,345 total trials

What the Registry Record Tells You About NCT02937870

The ClinicalTrials.gov registry entry for NCT02937870 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Denture Retention appearing as the primary indexed condition, and to 4 interventions - of which Test Product 1 is the first listed.

NCT02937870 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT02937870 about?

NCT02937870 is a clinical study titled "A Bite Force Study Comparing Two New Test Adhesives With Currently Marketed Denture Adhesive". The objective of this 4-treatment, 4-period, randomized, crossover, proof of principle bite force study will be to compare bite force measurements over a 12 hour period across two (test) cream denture adhesives, with a currently marketed cream denture adhesive (positive control), and a negative/no t...

What is the current status of trial NCT02937870?

This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2017-03-07. Estimated completion is 2017-04-05.

What conditions does trial NCT02937870 study?

This clinical trial studies the following conditions: Denture Retention.

What interventions are being tested in trial NCT02937870?

The interventions under investigation include: Test Product 1 (DEVICE), Test Product 2 (DEVICE), Reference Product (DEVICE), Negative Control (OTHER).

Who is sponsoring clinical trial NCT02937870?

This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02937870 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Denture Retention

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.